WeVote

Bill

Bill

HR 22

URGING THE UNITED STATES CONGRESS TO PASS H.R. 2687, ALSO KNOWN AS THE END KIDNEY DEATHS ACT.

2026 Regular Session Introduced by Della Belatti and 11 co-sponsors

Hawaii urges Congress to pass federal kidney disease legislation aimed at reducing mortality through improved prevention and treatment access.

Referred to HLT, JHA, referral sheet 15
0
WeVote Research Nonpartisan
Bill Summary · HR 22

Legislative bill overview

This is a Hawaii state resolution urging Congress to pass H.R. 2687, the "End Kidney Deaths Act," a federal bill addressing kidney disease mortality and treatment. The resolution does not create state law itself but rather advocates for federal legislative action on kidney disease prevention and management.

Why is this important

Kidney disease affects millions of Americans and represents a significant public health burden, with dialysis and transplant costs consuming substantial healthcare resources. A resolution elevating this issue signals state-level support for federal investment in kidney disease research, prevention, and treatment access—potentially influencing congressional consideration of the underlying federal bill.

Potential points of contention

  • Scope and cost of federal action: The underlying H.R. 2687 may involve significant federal spending or regulatory changes that could face opposition on fiscal grounds
  • Treatment approach philosophy: Different stakeholders (patient advocates, medical professionals, insurers, pharmaceutical companies) may disagree on whether solutions should emphasize prevention, dialysis expansion, transplant access, or other interventions
  • State vs. federal authority: Some may question whether a state resolution on federal healthcare policy is an appropriate use of state legislative resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.